St Jude Medical Inc (STJ:US)

St Jude Medical Inc News

• Boston Scientific’s Stroke Device Shows Mixed Results

  Boston Scientific Corp.’s Watchman, designed to help prevent strokes in patients with an erratic heartbeat, may be a tougher sell for U.S. regulators after a study failed to confirm the device’s benefit.

• Boston Scientific’s Watchman Heart Device Was Safer in Study

  Boston Scientific Corp.’s Watchman device, designed to help prevent strokes in patients with an erratic heartbeat, was safer than previously thought in a second study requested by U.S. regulators, researchers said.

• Deep-Brain Stimulation May Help Hard-to-Treat Anorexics

  Deep-brain stimulation, a technique that has shown promise in treating mental disorders as well as Parkinson’s disease, may also help severe and enduring anorexia, a small, early-stage study suggests.

• Boston Scientific’s Study at Heart Meeting Under Review

  Boston Scientific Corp.’s study of a heart device to reduce stroke risk, slated for presentation at a medical heart meeting this weekend, is under review after the company said only limited data about the product’s safety would be released.

• St. Jude Recalls System to Help Hole-in-Heart Therapy

  St. Jude Medical Inc. recalled a new delivery system used to treat people with a dangerous hole in the heart after discovering the device could fracture in a small number of cases, U.S. regulators said.

• Medtronic’s Brain Device Improves Early-Stage Parkinson’s

  Patients with early Parkinson’s disease who respond to drug therapy gain improvement in their symptoms and quality of life when they receive deep-brain stimulation from an implanted medical device, a study showed.

• Heart-Block Test Could Bring Volcano, St. Jude $2 Billion

  Volcano Corp.’s test that shows which patients need heart stents could lead to a $2 billion market within a decade as more doctors use it to improve care, Chief Executive Officer Scott Huennekens said.

• Brainsway Sees Partnership as FDA Backs Depression Device

  Brainsway Ltd. expects to reach an agreement this quarter for a medical-device company to market its non-invasive system to treat depression in the U.S., Chief Executive Officer Uzi Sofer said. The stock rose to the highest in almost three years.

• St. Jude Gets FDA Warning for Manufacturing Violations

  St. Jude Medical Inc., a maker of devices for irregular heartbeats, said it received a warning from U.S. regulators last week for deviating from unspecified good manufacturing practices at its Sylmar, California, plant.

• St. Jude Medical’s Fourth-Quarter Profit Tops Estimates

  St. Jude Medical Inc., a maker of heart rhythm devices, released preliminary fourth-quarter earnings that topped analysts’ estimates on higher-than- anticipated revenue and greater cost savings.

Related Topics

• 

  Minnesota

• 

  Europe

• 

  New York

• 

  San Francisco

Most Popular on Bloomberg

• JPMorgan Names Zames Sole Bank COO as Bisignano Joins First Data

• European Leaders’ Softening on Austerity May Accelerate

• Iraq Said to Halt Al Jazeera’s License, Closes Jordanian Border

• Shoppers Turn Blind Eye to Bangladesh in $6 Bikini Hunt

• Nokia Betting on $20 Handset as It Loses Ground on IPhone

St Jude Medical Inc Videos

Audio

• Morgan Joseph’s Jackson on Medical Equities: TakingStock